One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

As well as triggering weight loss – a result ... UCL who looked at data from the Select trial found that semaglutide lowers the risk of heart attacks, strokes and death due to cardiovascular ...

Eli Lilly said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide in 2025, a few months earlier than expected. The company expects to provide ...

These new weight loss drugs have shown promising results in reducing obesity and related complications like type 2 diabetes and cardiovascular disease. If made accessible and affordable ...

The U.S. imported about $427 billion worth of goods from China in 2023, the most recent year with complete data, according to ... scrutiny in recent years due to the rapidly growing number of ...